In order to determine whether enhanced inflammation and tissue destruction of the epithelial barrier during DSS colitis is causative of enhanced activation-dependent potential of Nr2f6−/− CD4+ (CD25−CD62LhiCD44lo) T cells, we used a model of T cell-dependent colitis. This evidence concerns the gene NR2F6 and colitis.